Telomir (TELO) news
Recent news
Telomir Pharmaceuticals - appoints Andriy Mushak as fractional CFO effective June 6, 2026 - SEC filing
Telomir Pharmaceuticals has announced the appointment of Andriy Mushak as fractional Chief Financial Officer, effective June 6, 2026, as disclosed in a recent SEC filing . The filing confirms Mushak’s role in overseeing the company’s financial strategy and operations on a part-time basis. No…
AInvest Wire · Jun 8, 2026Telomir Pharmaceuticals - Alan Weichselbaum to step down as CFO effective June 6, 2026 - SEC filing
Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) has filed a report with the U.S. Securities and Exchange Commission (SEC) indicating that Alan Weichselbaum will step down as Chief Financial Officer effective June 6, 2026. The announcement is detailed in the company’s recent SEC filing, which outlines…
AInvest Wire · Jun 8, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.